IG
NVS icon

ING Group’s Novartis NVS Stock Holding History

ING Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-66,043
Closed -$4.54M – 749
2013
Q3 		$4.54M Buy
+66,043
New +$4.37M 0.02% 402

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

ING Group's NVS Position: Q4 2013 in Review

ING Group sold out of Novartis (NVS) in Q4 2013, closing a stake of 66,043 shares — an estimated $4.54M sold.

ING Group first reported a position in NVS in Q3 2013 and held it in 1 quarter. The position peaked at $4.54M in Q3 2013. 816 funds tracked by Wall St. Rank hold NVS as of Q4 2013.

  • ING Group reported no remaining Novartis position as of Q4 2013 after selling out during the quarter.
  • ING Group sold 66,043 Novartis shares in Q4 2013, an estimated $4.54M.
  • ING Group first reported a position in Novartis in Q3 2013 and held it in 1 quarter.
  • ING Group's Novartis position peaked at $4.54M in Q3 2013.
  • 816 funds tracked by Wall St. Rank held Novartis as of Q4 2013.

Based on ING Group's 13F filing for Q4 2013, filed 14 Feb 2014.